Show simple item record

dc.contributor.authorSharpe, Bradley A.en_US
dc.contributor.authorFlanders, Scott A.en_US
dc.date.accessioned2007-05-02T14:19:34Z
dc.date.available2007-05-02T14:19:34Z
dc.date.issued2006-05en_US
dc.identifier.citationSharpe, Bradley A.; Flanders, Scott A. (2006). "Community-acquired pneumonia: A practical approach to management for the hospitalist." Journal of Hospital Medicine 1(3): 177-190. <http://hdl.handle.net/2027.42/50681>en_US
dc.identifier.issn1553-5592en_US
dc.identifier.issn1553-5606en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/50681
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17219492&dopt=citationen_US
dc.description.abstractCommunity-acquired pneumonia (CAP) is common, and inpatient physicians should be familiar with the most current evidence about and guidelines for CAP management. Our conclusions and recommendations include: Streptococcus pneumoniae is the most common identified cause of CAP requiring hospitalization, whereas Legionella pneumophila is a common cause of severe CAP. The chest radiograph remains an essential initial test in the diagnosis of CAP and should be supplemented by blood cultures sampled prior to antibiotic therapy and sputum for gram stain and culture if a high-quality specimen can be rapidly processed. Once the diagnosis is made, the Pneumonia Severity Index (PSI) should be used to optimize the location of treatment and to provide prognostic information. Absent other mitigating factors, patients in PSI risk classes I, II, and III can safely be treated as outpatients. Hospitalized patients with CAP should be treated promptly with empiric antibiotics. Nonsevere pneumonia should be treated with a parenteral Β-lactam plus either doxycycline or a macrolide. Patients admitted to the intensive care unit should be treated with a Β-lactam plus either a macrolide or a fluoroquinolone as well as be evaluated for pseudomonal risk factors. Most patients with nonsevere CAP reach clinical stability in 2–3 days and should be considered for a switch to oral therapy and discharge shortly thereafter. Patients should receive pneumococcal vaccination, influenza vaccination, and tobacco cessation counseling prior to discharge if eligible. Multiple quality indicators are measured and publicly reported in the management of CAP, which provides hospitals with an opportunity to improve care processes and patient outcomes. Journal of Hospital Medicine 2006;1:177–190. © 2006 Society of Hospital Medicine.en_US
dc.format.extent254490 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherHospital Medicineen_US
dc.titleCommunity-acquired pneumonia: A practical approach to management for the hospitalisten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan, Ann Arbor, Michigan ; Dr Flanders received speakers' honoraria from Elan, Pfizer, and Ortho-McNeil.en_US
dc.contributor.affiliationotherUCSF Department of Medicine, San Francisco, California ; UCSF Department of Medicine, 505 Parnassus Avenue, Box 0131, San Francisco, CA 94143; Fax: (415) 502-6235en_US
dc.identifier.pmid17219492en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/50681/1/95_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/jhm.95en_US
dc.identifier.sourceJournal of Hospital Medicineen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record